Aurobindo Pharma completed its acquisition of Lannett Company for $250 million in cash.
Aurobindo is a leading global pharmaceutical company that manufactures and markets active pharmaceutical ingredients, generic pharmaceuticals and related services.
Lannett manufactures and supplies complex generic pharmaceuticals, including DEA-controlled substances.
The S&C team advising Aurobindo includes Eric Krautheimer, Sahand Moarefy and Ryan Nober. Rita-Anne O’Neill advised on R&W insurance matters. Tessa Lee and Jeremy Zeitschel advised on tax matters. Sarah Remmer Long and Lauren Appel advised on executive compensation matters. Stella Meyer advised on labor and employment matters. Rachel Yu, Elizabeth Levin and April Yu advised on intellectual property matters. Samantha Hynes advised on antitrust matters. Juan Rodriguez and Daniela Hohwieler advised on ex-U.S. regulatory matters. Brandon Wallace advised on litigation diligence matters.